Journal
NATURE NEUROSCIENCE
Volume 17, Issue 3, Pages 357-U48Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nn.3639
Keywords
-
Categories
Funding
- NIH [U24NS050606]
- Ruth L. Kirschstein National Research Service Award [F32AG039193, R01AG33518]
- Ellison Medical Foundation
- American Health Assistance Foundation/BrightFocus
- US National Institutes of Health [1R21NS070250]
- National Science Foundation [0954570]
- University of Florida Department of Neuroscience
- Direct For Social, Behav & Economic Scie
- Division Of Behavioral and Cognitive Sci [0954570] Funding Source: National Science Foundation
Ask authors/readers for more resources
The microtubule-associated protein tau is involved in a number of neurodegenerative disorders, including Alzheimer's disease. Previous studies have linked oxidative stress and subsequent DNA damage to neuronal death in Alzheimer's disease and related tauopathies. Given that DNA damage can substantially alter chromatin structure, we examined epigenetic changes in tau-induced neurodegeneration. We found widespread loss of heterochromatin in tau transgenic Drosophila and mice and in human Alzheimer's disease. Notably, genetic rescue of tau-induced heterochromatin loss substantially reduced neurodegeneration in Drosophila. We identified oxidative stress and subsequent DNA damage as a mechanistic link between transgenic tau expression and heterochromatin relaxation, and found that heterochromatin loss permitted aberrant gene expression in tauopathies. Furthermore, large-scale analyses from the brains of individuals with Alzheimer's disease revealed a widespread transcriptional increase in genes that were heterochromatically silenced in controls. Our results establish heterochromatin loss as a toxic effector of tau-induced neurodegeneration and identify chromatin structure as a potential therapeutic target in Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available